![]() |
市场调查报告书
商品编码
1384652
全球支气管镜市场规模、份额、产业趋势分析报告:2023-2030 年按类型、应用、最终用途、地区分類的展望与预测Global Bronchoscopes Market Size, Share & Industry Trends Analysis Report By Type (Flexible (Video, Fiberoptic, Hybrid), and Rigid), By Usage, By End Use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030 |
到 2030 年,支气管镜市场规模预计将达到 44 亿美元,预测期内复合年增长率为 6.9%。 2022年市场规模为1,308,100台,成长率为9.6%(2019-2022年)。
根据 KBV 基数矩阵中的分析,强生公司是该市场的领导者。美敦力公司、富士软片控股公司和奥林巴斯公司等公司是市场上的主要创新者。 2022年7月,美敦力宣布推出Illumicite,这是一个用于支气管镜手术的系统。该系统具有多种优势,包括微创设备、更好地观察组织异常情况以及扩大对病变的接触范围。
COVID-19 影响分析
呼吸系统是受 COVID-19 影响最严重的系统,导致对支气管镜和其他呼吸诊断工具的需求激增。医院和医疗机构需要支气管镜检查来诊断和治疗 COVID-19 患者,特别是那些有严重呼吸道症状的患者。许多医疗机构必须重新分配资源并优先考虑与 COVID-19 相关的护理和设备。此次疫情加速了医疗保健领域的研发,包括新医疗设备和技术的开发。结果,支气管镜的设计和功能发生了革命性的变化。感染控制已成为医疗机构的首要任务。製造商和医疗保健提供者加强了支气管镜灭菌和清洗方案,以降低交叉污染的风险。因此,COVID-19的爆发对市场产生了温和的影响。
市场成长要素
呼吸道疾病增加
肺癌、慢性阻塞性肺病(COPD)、气喘和肺炎等呼吸系统疾病的盛行率不断增加,推动了对支气管镜检查诊断和治疗的需求。肺癌是全球癌症相关死亡的主要原因之一。诊断、分期和治疗计划通常需要支气管镜手术。透过支气管镜检查进行早期发现和准确诊断对于提高存活率至关重要。 COPD 是一种包括慢性支气管炎和肺气肿的疾病。支气管镜检查可评估气道发炎,采集组织样本进行诊断,并提供治疗性介入来控制症状和改善肺功能。呼吸系统疾病盛行率的上升是市场成长的关键驱动力。
扩大远端医疗和远距会诊的采用
远端医疗和远距医疗保健服务的发展扩大了支气管镜检查治疗的范围。视讯支气管镜允许医疗保健专业人员进行远端咨询并与专家合作。远端医疗使偏远和服务欠缺地区的患者能够获得医疗保健服务,包括支气管镜检查和后续护理,而无需远距前往医疗机构。我会成功的。远端医疗允许医疗保健提供者远距与患者进行咨询。您可以与专家共用您的支气管镜检查观察、图像和视频,以进行评估和建议,这样无论您身在何处,都可以听到他们的意见。远端医疗和远距医疗保健服务的成长正在对市场产生重大影响。
市场抑制因素
感染风险高
支气管镜手术有感染疾病的风险。确保支气管镜的正确清洗、消毒和灭菌对于预防医疗相关感染至关重要。支气管镜是复杂的医疗设备,具有多个通道和组件,使得彻底清洗变得困难。包括微生物生物膜在内的污染物可能隐藏在缝隙和通道中,增加感染传播的风险。清洗和再处理支气管镜时的人为错误是一个严重的问题。手动清洗、消毒和灭菌错误可能会留下持有传染性病原体的污染物。因此,感染丛集和爆发的检测可能会被延迟。与支气管镜检查相关的感染传播风险是医疗保健产业和市场的重大挑战。
按类型分類的展望
内视镜市场分为刚性型和柔性型。 2022 年,光纤领域在市场中占据了重要的收益占有率。柔性支气管镜直径较小,侵入性较小,可减少患者在手术过程中的不适和焦虑。柔性支气管镜用途广泛,可用于各种诊断和治疗过程。适合观察整个气道,包括支气管和周围气道。由于其弹性,柔性内视镜很容易在气道内操纵和导航。柔性支气管镜的优点包括患者友善设计、多功能性、先进的影像处理功能以及适合各种诊断和治疗应用。支气管镜检查已成为呼吸医学的标准工具,在肺部和气道疾病的诊断和治疗中发挥重要作用。
灵活的前景
在柔性类型中,市场分为视讯、光纤和混合。在2022年的市场中,光纤领域获得了可观的收益占有率。纤维支气管镜检查通常用于诊断目的。医疗保健提供者可以检查支气管树并检测肿瘤、感染、外来物和发炎等异常情况。光纤束提供的光学清晰度可实现精确的可视化。纤维支气管镜检查用于检查气道、评估气道通畅性并识别阻塞和病变。它是评估患有咳嗽、咯血和喘息等呼吸道症状的患者的宝贵工具。纤维支气管镜用于定位和清除气道中的异物,例如食物颗粒或吸入物。支气管镜的弹性和可操作性有助于提高这些手术的准确性。
按用途分類的展望
依应用划分,市场分为可重复使用型和一次性型。到 2022 年,一次性细分市场将占据重要的市场收益占有率份额。一次性支气管镜是在受控条件下製造的,确保每个范围都是最佳的。这种一致性对于影像品质和功能至关重要的关键程序尤其重要。医疗保健提供者发现一次性支气管镜很方便,因为它们不需要设定、校准或灭菌并且可以立即使用。这在紧急情况下尤其有利。一次性支气管镜适用于使用后处理设施有限或不切实际的偏远或现场位置。
最终用途展望
根据最终用途,市场分为医院和门诊设施。 2022年,医院细分市场收益占有率最大。医院使用支气管镜进行诊断。将支气管镜插入患者气道以观察气管、支气管和支气管。这使我们能够识别肿瘤、感染、发炎和出血等异常情况。也可以使用支气管镜从气道采集组织样本,并将其送到病理部门进行分析。在医院,支气管镜用于治疗目的。它用于给药、进行支气管热成形术以治疗气喘以及治疗咳血(吐血)和狭窄(气道变窄)等疾病。
区域展望
按地区划分,对北美、欧洲、亚太地区和拉丁美洲地区市场进行了分析。 2022年,北美地区以最高的收益占有率引领市场。该地区先进的医疗基础设施允许引进最新的医疗技术和医疗设备,包括支气管镜检查。优质的医疗设施和熟练的劳动力正在促进市场的成长。北美是医疗创新中心。该地区的製造商继续开发和引进先进的支气管镜技术,包括提供更高清晰度影像、改进的可操作性以及与数位系统整合的数位位视讯支气管镜。
The Global Bronchoscopes Market size is expected to reach $4.4 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,308.1 thousand units, experiencing a growth of 9.6% (2019-2022).
Video bronchoscopes have high-resolution cameras and advanced imaging technologies, such as high-definition (HD) and 4K video capabilities. Hence, video segment would acquire approximately 1/2th share in the Flexible segment of the market by 2030. These technologies provide clear and detailed images of the respiratory tract, allowing healthcare professionals to visualize and assess the airway more effectively. Video bronchoscopes offer real-time visualization of the airway during procedures. This real-time feedback is crucial for diagnosing conditions, guiding interventions, and ensuring patient safety. Video bronchoscopes allow healthcare providers to document procedures by recording video and capturing images. This documentation can be used for patient records, education, and consultation with colleagues, contributing to improved patient care.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope. In November, 2022, Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter.
Based on the Analysis presented in the KBV Cardinal matrix; Johnson & Johnson is the forerunner in the Market. Companies such as Medtronic PLC, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in the Market. In July, 2022, Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
COVID-19 Impact Analysis
The respiratory system was the system that COVID-19 most affected, which caused a spike in demand for bronchoscopes and other diagnostic tools for the respiratory system. Hospitals and healthcare facilities needed bronchoscopes to diagnose and treat COVID-19 patients, especially those with severe respiratory symptoms. Many healthcare facilities had to reallocate resources and prioritize COVID-19-related care and equipment. The pandemic accelerated research and development efforts in the healthcare sector, including developing new medical devices and technologies. This led to innovations in bronchoscope design and functionality. Infection control measures became a top priority in healthcare settings. Manufacturers and healthcare providers implemented enhanced sterilization and cleaning protocols for bronchoscopes to reduce the risk of cross-contamination. Therefore, COVID-19 pandemic had a moderate effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
The increasing incidence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and pneumonia has driven the demand for bronchoscopic procedures for diagnosis and treatment. Lung cancer is one of the leading causes of cancer-related deaths globally. It often requires bronchoscopic procedures for diagnosis, staging, and treatment planning. Early detection and accurate diagnosis through bronchoscopy are critical for improving survival rates. COPD comprises conditions including chronic bronchitis and emphysema. It assess airway inflammation, collect tissue samples for diagnosis, and provide therapeutic interventions to manage symptoms and improve lung function. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Growing adoption of telemedicine and remote consultations
The growth of telemedicine and remote healthcare services has expanded the reach of bronchoscopic procedures. Video bronchoscopes enable healthcare professionals to conduct remote consultations and collaborate with specialists. Telemedicine authorizes patients in remote or underserved areas to access healthcare services, including bronchoscopic consultations and follow-up care, without traveling long distances to a healthcare facility. Telemedicine enables healthcare providers to conduct remote consultations with patients. Bronchoscopic findings, images, and videos can be shared with specialists for evaluation and recommendations, allowing expert input regardless of geographical location. The growth of telemedicine and remote healthcare services has significantly impacted the market.
Market Restraining Factors
Higher risk of infection transmission
Bronchoscopic procedures carry the risk of infection transmission. Ensuring proper cleaning, disinfection, and sterilization of bronchoscopes is crucial to prevent healthcare-associated infections. Bronchoscopes are intricate medical devices with multiple channels and components, which makes them challenging to clean thoroughly. Contaminants, including microbial biofilms, can hide in crevices and channels, increasing the risk of infection transmission. Human error during the cleaning and reprocessing of bronchoscopes is a significant concern. Manual cleaning, disinfection, or sterilization errors can leave behind contaminants that harbour infectious agents. This can result in delayed recognition of infection clusters or outbreaks. The risk of infection transmission associated with bronchoscopes presents a significant challenge in the healthcare industry and the market.
Type Outlook
Based on type, the market is classified into rigid and flexible. The fiberoptic segment garnered a significant revenue share in the market in 2022. Flexible bronchoscopes have a smaller diameter and are less invasive, which can reduce patient discomfort and anxiety during the procedure. Flexible bronchoscopes are highly versatile and can be used for various diagnostic and therapeutic procedures. They are suitable for visualizing the entire respiratory tract, including the bronchi and peripheral airways. Flexible bronchoscopes are easier to maneuver and navigate through the airways due to their flexibility. The advantages of flexible bronchoscopes include their patient-friendly design, versatility, advanced imaging capabilities, and suitability for various diagnostic and therapeutic applications. They have become a standard tool in respiratory medicine and play a significant role in diagnosing and treating lung and airway disorders.
Flexible Outlook
Under flexible type, the market is divided into video, fiberoptic, and hybrid. The fiberoptic segment garnered a significant revenue share in the market in 2022. Fiberoptic bronchoscopes are commonly used for diagnostic purposes. They allow healthcare providers to examine the bronchial tree and detect abnormalities like tumours, infections, foreign bodies, and inflammation. The optical clarity provided by fiberoptic bundles enables precise visualization. Fiberoptic bronchoscopes are used to inspect the airway, assess airway patency, and identify any obstructions or lesions. They are valuable tools for evaluating patients with respiratory symptoms, including cough, hemoptysis, and wheezing. Fiberoptic bronchoscopes are used to locate and remove foreign objects, such as food particles or inhaled objects, from the airway. Their flexibility and maneuverability aid in precision during these procedures.
Usage Outlook
By usage, the market is categorized into reusable and disposable. The disposable segment covered a considerable revenue share in the market in 2022. Disposable bronchoscopes are manufactured under controlled conditions, ensuring that each scope is optimal. This consistency can be especially important for critical procedures where image quality and functionality are essential. Healthcare providers find disposable bronchoscopes convenient because they can be used immediately without the need for setup, calibration, or sterilization. This can be particularly advantageous in emergencies. Disposable bronchoscopes are well-suited for use in remote or field settings where access to reprocessing facilities is limited or impractical.
End Use Outlook
On the basis of end-use, the market is segmented into hospitals and outpatient facilities. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals use bronchoscopes for diagnostic purposes. These procedures involve the insertion of the bronchoscope into the patient's airways to visualize the trachea, bronchi, and bronchioles. This helps identify abnormalities like tumours, infections, inflammation, and bleeding. It enables the collection of tissue samples from the airways, which are then sent to the pathology department for analysis. Hospitals utilize bronchoscopes for therapeutic purposes. They can be used to deliver medications, perform bronchial thermoplasty for asthma management, or treat conditions like hemoptysis (coughing up blood) or strictures (narrowing of airways).
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The region's advanced healthcare infrastructure enables the adoption of the latest medical technologies and devices, including bronchoscopes. High-quality healthcare facilities and a skilled workforce contribute to the market's growth. North America is a hub for medical technology innovation. Manufacturers in the region continually develop and introduce advanced bronchoscope technologies, such as digital video bronchoscopes with high-definition imaging, enhanced manoeuvrability, and integration with digital systems.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Olympus Corporation, Ambu A/S, Karl Storz SE & Co. KG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Johnson & Johnson, Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)
Recent Strategies Deployed in Bronchoscopes Market
Product Launches and Product Expansions:
Jan-2023: Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope.
Nov-2022: Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter. Additionally, it has a teardrop-shaped dial which facilitates smooth handling during procedures.
Jul-2022: Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
Apr-2021: Olympus Corporation announced the launch of H-SteriScope Single-Use Bronchoscopes, a series of five single-use endoscopes used for diagnostic and therapeutic procedures. The bronchoscopes feature an outer diameter range of 2.2 to 6.2 mm and working channels that span 1.2 to 3.2 mm. Additionally, the bronchopes have a rotary function for east positioning and Tip Angulation for easy target access.
Mergers & Acquisition:
Sep-2021: Boston Scientific Corporation took over the international surgical business of Lumenis, a medical device manufacturer based in Israel. The acquisition complements Boston Scientific's kidney stone management portfolio and expands its presence in Europe and Asia.
Jun-2021: Boston Scientific Corporation announced the acquisition of Farapulse Inc., a medical device manufacturing company. The acquisition complements and strengthens Boston Scientific's electrophysiology portfolio.
Partnerships, Collaborations & Agreements:
Apr-2023: Fujifilm Holdings Corporation partnered with Tata Memorial Center, an Indian cancer research institute, to establish a training facility in the Tata Memorial Center. The partnership comes in line with Fujifilm's aim to improve healthcare in the Indian market.
Trials and Approvals:
Jul-2022: Ambu A/S received approval from the US FDA for its Ambu aScopeTM 5 Broncho, a series of single-use sterile bronchoscopes.
Aug-2021: Boston Scientific Corporation announced the US FDA approval for its announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT Model B Single-Use Bronchoscope. The EXALT Model B Bronchoscope is used for a variety of bronchoscopy procedures including secretion management, percutaneous tracheostomy, airway intubation, etc.
Market Segments covered in the Report:
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Usage (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research